SCHEMBL5407475

SCHEMBL5407475

CC(C)Cn1ccc(=O)n(NN)c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
ACACB O00763 1/20 0.34
TLR7 Q9NYK1 1/20 0.33
HSD17B10 Q99714 3/20 0.32
TSHR P16473 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SLC2A1 P11166 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
ALOX15 P16050 1/20 0.31
CYP2C19 P33261 1/20 0.31
GRIK3 Q13003 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HTR2A P28223 2/20 0.30
HTR2C P28335 2/20 0.30
POLB P06746 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2456869 0.75 ALDH1A1 (0.46) ALDH1A1HSD17B10TSHRL3MBTL1SMN1; SMN2
SCHEMBL24664732 0.72 RGS4 (0.39) ALDH1A1HSD17B10TSHRL3MBTL1SMN1; SMN2
SCHEMBL14478207 0.66 HTR2C (0.41) ALDH1A1HTR2AHTR2C
SCHEMBL17563245 0.65 ACACB (0.43) ALDH1A1ACACBHSD17B10TSHRL3MBTL1
SCHEMBL25045667 0.63 BRD4 (0.36) ALDH1A1TLR7HSD17B10TSHRL3MBTL1
SCHEMBL2608934 0.63 PSMB1 (0.47) TLR7HSD17B10TSHRL3MBTL1SMN1; SMN2
SCHEMBL470116 0.63 ACACB (0.42) ALDH1A1ACACBTLR7HSD17B10TSHR
SCHEMBL12652844 0.62 FGFR1 (0.51) TLR7SLC2A1HTR2AHTR2CPOLB
SCHEMBL7133033 0.61 PKM (0.65) ALDH1A1L3MBTL1PKM
SCHEMBL10967101 0.61 ALDH1A1 (0.46) ALDH1A1HSD17B10TSHRL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285558-B2 Pyrazolo[3,4-d]pyrimidines inhibiting H. pylori infections ASTRAZENECA AB (SE) 2007-10-23 US disclosed
US-20040254183-A1 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections ASTRAZENECA AB (SE) 2004-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254183-A1 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections DPYD, HPGDS, PGC ALDH1A1 903/4885ACACB 4247/4885TLR7 2132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.